期刊
MOLECULAR PHARMACOLOGY
卷 101, 期 2, 页码 68-77出版社
AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
DOI: 10.1124/molpharm.121.000385
关键词
-
资金
- National Institutes of Health National Insti-tute of General Medical Sciences [R01GM108580, R35GM140947]
- Taylor Family Institute for Innovative Psychiatric Research
This study demonstrates that inhibitory steroids pregnenolone sulfate and dehydroepiandrosterone sulfate act through a common interaction site by stabilizing a distinct non-conducting state.
The GABA(A) receptor is inhibited by the endogenous sulfated steroids pregnenolone sulfate (PS) and dehydroepiandroster-one sulfate (DHEAS). It has been proposed in previous work that these steroids act by enhancing desensitization of the receptor. Here, we have investigated the modulatory effects of the steroids on the human a1b3c2L GABA(A) receptor. Using electrophysiology and quantitative model-based data analy-sis, we show that exposure to the steroid promotes occu-pancy of a nonconducting state that retains high affinity to the transmitter but whose properties differ from those of the clas-sic, transmitter-induced desensitized state. From the analysis of the inhibitory actions of two combined steroids, we infer that PS and DHEAS act through shared or overlapping binding sites. SIGNIFICANCE STATEMENT Previous work has proposed that sulfated neurosteroids inhibit the GABA(A) receptor by enhancing the rate of entry into the desensitized state. This study shows that the inhibitory steroids pregnenolone sulfate and dehydroepiandrosterone sulfate act through a common interaction site by stabilizing a distinct non-conducting state.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据